Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Leases (2019 - 2026)

Usana Health Sciences (USNA) has disclosed Leases for 6 consecutive years, with $23.0 million as the latest value for Q1 2026.

  • Quarterly Leases rose 8.39% to $23.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $23.0 million through Jan 2026, up 8.39% year-over-year, with the annual reading at $23.0 million for FY2026, 8.39% up from the prior year.
  • Leases for Q1 2026 was $23.0 million at Usana Health Sciences, up from $21.2 million in the prior quarter.
  • The five-year high for Leases was $23.8 million in Q1 2022, with the low at $17.7 million in Q4 2023.
  • Average Leases over 4 years is $21.1 million, with a median of $21.2 million recorded in 2024.
  • The sharpest move saw Leases dropped 15.94% in 2022, then grew 19.84% in 2024.
  • Over 4 years, Leases stood at $20.0 million in 2022, then dropped by 11.63% to $17.7 million in 2023, then increased by 19.84% to $21.2 million in 2024, then grew by 8.39% to $23.0 million in 2026.
  • According to Business Quant data, Leases over the past three periods came in at $23.0 million, $21.2 million, and $17.7 million for Q1 2026, Q4 2024, and Q4 2023 respectively.